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ABSTRACT
Artificial intelligence (AI) is evolving in the field of diagnostic medical imaging, including 
echocardiography. Although the dynamic nature of echocardiography presents challenges 
beyond those of static images from X-ray, computed tomography, magnetic resonance, 
and radioisotope imaging, AI has influenced all steps of echocardiography, from image 
acquisition to automatic measurement and interpretation. Considering that echocardiography 
often is affected by inter-observer variability and shows a strong dependence on the level 
of experience, AI could be extremely advantageous in minimizing observer variation and 
providing reproducible measures, enabling accurate diagnosis. Currently, most reported AI 
applications in echocardiographic measurement have focused on improved image acquisition 
and automation of repetitive and tedious tasks; however, the role of AI applications should 
not be limited to conventional processes. Rather, AI could provide clinically important 
insights from subtle and non-specific data, such as changes in myocardial texture in 
patients with myocardial disease. Recent initiatives to develop large echocardiographic 
databases can facilitate development of AI applications. The ultimate goal of applying AI 
to echocardiography is automation of the entire process of echocardiogram analysis. Once 
automatic analysis becomes reliable, workflows in clinical echocardiographic will change 
radically. The human expert will remain the master controlling the overall diagnostic process, 
will not be replaced by AI, and will obtain significant support from AI systems to guide 
acquisition, perform measurements, and integrate and compare data on request.
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INTRODUCTION
There is widespread acknowledgment that artificial intelligence (AI) will transform the 
healthcare system, particularly in the field of diagnostic medical imaging.1) The use of AI 
in diagnostic medical imaging has undergone extensive evolution, and there are currently 
computer vision systems that perform some clinical image interpretation tasks at the level 
of expert physicians.2)3) Furthermore, the potential applications of AI are not limited to 
image interpretation, but also include image acquisition, processing, reporting, and follow-
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up planning.4) Although AI has been applied mostly to static images from X-ray, computed 
tomography (CT), magnetic resonance (MR), and radioisotope imaging, many companies 
and investigators have recently sought to address challenges such as the dynamic nature of 
echocardiography through AI.5)6) Many areas in echocardiography have been impacted by AI, 
and AI-based software that aids in echocardiography measurement is commercially available.
Because of the continuously increasing number of patients with cardiovascular disease 
and the parallel growth in demand for echocardiographic studies, there is a supply-
demand mismatch between patient volume and number of experts available to interpret 
echocardiographic studies not only in the laboratory, but also at the point-of-care.7) 
Therefore, AI, which can offer sustainable solutions to reduce workloads (e.g., aid in the 
repetitive and tedious tasks involved in echocardiography measurement and interpretation), 
should be viewed as a growth opportunity rather than as a disruption.8) Many issues remain 
that must be addressed to implement AI applications in daily clinical practice. In this review, 
we provide an overview of the current state of AI in echocardiography and the challenges that 
are being confronted. Further, we aimed to analyze various aspects of incorporating AI in the 
clinical workflow and provide insight into the future of echocardiography.
TERMINOLOGY
In broad terms, AI comprises the engineering of computerized systems able to perform tasks 
that typically require human intelligence. Machine learning (ML) provides systems the ability 
to learn and improve performance from experience without being explicitly programmed. 
Deep learning (DL) is a subfield of ML concerned with algorithms inspired by the structure 
and function of the human brain, known as artificial neural networks. Conventional ML 
usually requires derivation of knowledge-based hand-crafted features extracted from input 
images.9) However, DL networks can learn high-level features from big data, instead of by 
“feature engineering” processes. In DL training networks, all trainable weights are updated 
using backpropagation algorithms by minimizing the objective function, which is the 
difference between the ground truth and the prediction. In the inference phase, the trained 
network predicts results from the input image itself, without the need for hand-crafted 
imaging features.10) Especially in the field of imaging, convolutional neural networks (CNNs) 
are able to extract detailed low-level information from original images and combine them 
to form higher-order structural information, enabling identification of complex entities 
in unprocessed images. This technique has dramatically improved the accuracy of ML 
models, especially in the fields of visual object recognition and object detection.6) While 
CNNs successfully encode the spatial features of a single frame, recurrent neural networks 
(RNNs) are designed to interpret temporal or sequential information from videos, which 
are essentially a sequence of individual images.11)12) RNNs enable encoding of temporal 
dependencies between sequential images. Although RNNs have not been fully exploited, 
combined CNNs and RNNs have been designed to consider spatio-temporal features to 
achieve an accurate evaluation of echocardiograms by simultaneously extracting spatial 
features and retaining memory across image sequences.13)
AI learning can be classified into three categories: supervised learning, unsupervised 
learning, and reinforcement learning.6) The main difference between supervised and 
unsupervised learning is that unsupervised learning uses unlabeled data, whereas supervised 
learning uses labeled data. Supervised learning analyzes labeled training data and produces 
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an inferred function, which can be used for classification or prediction of new (untaught) 
input. Supervised learning techniques have shown great promise in medical image analysis, 
and the availability of large amounts of training data with manual labels has been crucial in 
many of these successes.14) For example, after training an algorithm with thousands of apical 
echocardiographic images with known left ventricular ejection fraction (LVEF), the algorithm 
was able to analyze images and produce an accurate LVEF identification.15) On the other hand, 
unsupervised learning aims to infer, from unlabeled data, the unknown natural structure or 
pattern present within a set of data points. However, supervised and unsupervised learning 
are not mutually exclusive. ML can integrate supervised and unsupervised learning as 
appropriate for semi-supervised learning.11) The final AI learning technique, reinforcement 
learning, is a method of learning from actions taken in surrounding environments to 
maximize cumulative rewards through trial and error.11)
ECHOCARDIOGRAPHIC IMAGE ACQUISITION
The first step in application of AI to echocardiography is image acquisition. Compared to 
static images that are based on radiation, image acquisition in echocardiography is much 
more experience-dependent. AI can help minimize inter- and intra-observer variation and 
aid in acquisition of standard images. For example, Narang et al.16) recently introduced 
a novel DL-derived technology that combines real-time image quality assessment with 
adaptive anatomic guidance to allow users with limited echocardiography training to 
acquire standard echocardiography images. The U.S. Food and Drug Administration (FDA) 
approved this AI-based echocardiographic device in February 2020, as the first such device 
to receive FDA approval.17) This new paradigm shift in AI applications can facilitate access 
to echocardiographic data in resource-limited settings or clinical situations requiring 
immediate interrogation of cardiac structure and function (e.g., emergency departments, 
primary care clinics, remote environments, and the developing world). In these situations, 
given that nonexpert users can perform limited echocardiographic examinations using 
handheld or portable machines with nonuniform quality and risk of nondiagnostic and 
misleading imaging, the potential use of AI guidance to improve the yield of point-of-
care ultrasound has tremendous appeal. The current condition for use of this AI-based 
echocardiographic device is that a cardiologist must review and approve the acquired images 
for patient evaluation, rather than leaving everything to the machine.6) The extent to which 
AI-based devices can be trusted is an important issue that should be discussed over time.
VIEW IDENTIFICATION
A typical 2-dimensional (2D) transthoracic echocardiogram collects close to 70 videos from 
different viewpoints to visualize the complex 3-dimensional (3D) cardiac structure from 
2D cross-sectional images. As such video clips do not necessarily have labeled views, view 
identification is an essential step in AI applications before training the deep neural network 
and proceeding with automatic measurement and image interpretation (Figure 1). Correct 
view identification must proceed to ensure an accurate evaluation of the echocardiogram. 
Furthermore, considering that a massive amount of labeled data is a prerequisite for DL 
algorithm training, a view identification algorithm that is able to handle this time-consuming 
and laborious preprocessing step is expected to facilitate the development of AI applications 
in echocardiography.
195https://e-jcvi.org https://doi.org/10.4250/jcvi.2021.0039
Artificial Intelligence and Echocardiography
Previous studies have proposed view classification models with accuracies around 91%–94% 
for 15-view classification.18)19) Although these models seem to work well, it is important to 
recognize that errors in the view classification step can cascade into errors in measurement 
or interpretation. Recently, Kusunose et al.20) reported on a CNN-based view classification 
algorithm with an overall accuracy of 98.1%. The authors then tested the prediction model 
for LVEF using learning data with a 1.9% error rate. Since LVEF prediction accuracy was 
verified, even with training data containing 1.9% mislabeled images, they suggested that 
their view classification model is feasible clinically. Although this previous study evaluated 
only the impact of view classification errors on LVEF prediction, it highlighted that view 
classification is not an independent step but a foundational step for automatic analysis of 
echocardiographic images.
View classification algorithms can change the way echocardiograms are read. Standard 
echocardiographic acquisitions often start with parasternal views, followed by apical views, 
and finally subcostal views. Therefore, acquisitions from multiple nonconsecutively acquired 
views must be integrated to arrive at a conclusion or diagnosis. For example, to evaluate 
aortic stenosis severity, the left ventricular (LV) outflow tract diameter from the parasternal 
long-axis view must be integrated with Doppler tracings of the LV outflow tract and aortic 
valve obtained from apical 3- or 5-chamber views and, occasionally, suprasternal views. 
Simultaneously, cardiologists must pay attention to LVEF, typically obtained from apical 2- 
and 4-chamber views. Advancement in AI-automated classification algorithms would allow 
echocardiograms to be read according to the particular valve or chamber being evaluated 
instead of by the sequence in which the images were acquired. If one submits a query for 
aortic valve area assessment, all relevant images would be displayed together, despite not 
being acquired consecutively. The same principle would apply to the parameters of LVEF, 
diastolic function, and valvular regurgitation.
SEGMENTATION AND MEASUREMENT
Once appropriate views have been determined, the next step is to measure the cardiac 
chamber size and function. To date, automatic cardiac segmentation in 2D and 3D 
transthoracic echocardiograms has focused on the LV due to the emerging needs for 
assessing left heart function, represented by the LVEF.21-23) Echocardiographic quantification 
of the LVEF requires accurate delineation of the LV endocardium in both end-diastole and 
end-systole. In daily clinical practice, semi-automatic or manual identification of endocardial 
borders is routine due to the current lack of accuracy and reproducibility for fully automatic 
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• Parasternal long axis view
• Parasternal short axis view
• Apical 4 chamber view
• Apical 2 chamber view
• Apical 3 chamber view
Figure 1. Illustration of a deep learning-based model for view identification. The model comprises convolutional layers that learn features for visual cues with a 
fully connected layer for view identification.
cardiac segmentation methods.23) Therefore, the field suffers from time-consuming tasks that 
are prone to intra- and inter-observer variability,24) indicating the need for a fast, accurate, 
and automated analysis of echocardiograms.
Despite remarkable advances in the quality of echocardiograms, issues of inhomogeneity in 
intensity, edge dropout, and low signal-to-noise ratio historically have impeded the clinical use 
of automatic segmentation platforms for an accurate and clinically acceptable calculation of 
chamber volumes. Nevertheless, multiple vendors, and even investigators, are addressing these 
issues and have demonstrated the ability to perform automated echocardiographic recognition 
and measure common 2D structural parameters (Figure 2).19)21-23) Automatic measurements are 
expected to become more time-efficient, representative, and reproducible.19)25) Furthermore, 
automatic measurements by algorithms need not be limited to a specific phase (i.e., end-
diastole or end-systole); rather, they can allow a frame-by-frame analysis of multiple cardiac 
cycles to provide a more precise evaluation.26) However, to date, such algorithms have been 
trained on private datasets, and their generalizability to other independent datasets remains 
undertested. In addition to the difficulty of obtaining a large number of echocardiographic 
images that have been carefully annotated by cardiologists, measurement variation 
associated with intrinsic beat-to-beat variability in cardiac function, as well as variability from 
approximating a 3D object using 2D cross-sectional images, has hampered the advent of 
clinically applicable algorithms. No automated method can be better than the images inputted. 
Considering that a 2D echocardiographic measure of chamber volume is limited by geometric 
assumptions and foreshortening, automated 2D echocardiographic volume measurement has 
innate limitations that cannot be overcome by the algorithms.
Due to the avoidance of both geometric assumptions and the risk of underestimating 
chamber volumes associated with foreshortened views, 3D transthoracic echocardiographic 
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Original image Ground truth AI prediction
Figure 2. Examples of endocardial border detection. Artificial intelligence algorithms show robust segmentation results (right columns) compared to the ground 
truth as determined by manual annotation (left columns). Left ventricle (red), left atrium (blue), right ventricle (green), right atrium (yellow).
measurements of cardiac chamber volumes are well-recognized to be superior in 
accuracy and reproducibility compared to 2D techniques.27) Therefore, recent guidelines 
recommend 3D echocardiographic quantification of the left heart chambers when 
possible.28) However, this methodology has not been widely embraced nor fully integrated 
into routine clinical work in most centers due to its extensive user input dependence, 
need for 3D expertise, and time-consuming workflow; most centers continue to rely on 
traditional 2D echocardiographic assessments of cardiac chamber volume and function. 
Therefore, the ultimate target of automated volume measurement algorithms should be 3D 
echocardiography rather than 2D echocardiography. The availability of a reasonably accurate 
and reproducible automated cardiac chamber quantification technique, requiring minimal or 
no manual correction of the endocardial borders, would potentially allow integration of 3D 
echocardiographic volumetric measurements into routine clinical practice.
Although 3D echocardiography has suffered from inferior image quality compared to that of 
contemporary 2D echocardiographic images,27) utilizing volumetric information can inform 
the boundaries by reference to adjacent slices. Furthermore, it is more straightforward to 
develop automated volumetric measurement algorithms for 3D echocardiography than for 
2D echocardiography due to its volumetric nature, which is free from the approximation 
process for volume estimation in 2D echocardiography using Simpson's method. Automated 
software (HeartModelA.I.; Philips Healthcare, Amsterdam, Netherlands) based on an adaptive 
analytic algorithm that provides LV and left atrial volumetric quantification is commercially 
available.29) Validation of this automated 3D transthoracic echocardiography software has 
shown its good accuracy and reproducibility, with a promising time-saving potential in 
patients with good images.30-33) Although border correction is required in patients with low 
image quality, to improve the accuracy of the automated measure,34) multiple refinements 
have been made in the continued development of the algorithm, resulting in improved 
endocardial boundary detection that requires minimal to no manual corrections, as well as 
an improved ability to analyze a larger percentage of the patient population.30) Furthermore, 
this methodology has been recently expanded to automatic measurement of chamber 
volumes throughout the cardiac cycle35) and to automated LV mass determination.36)
INTERPRETATION
Echocardiography is not only skill-dependent in acquisition of images; the interpretation 
of echocardiography remains highly subjective. AI holds promise in echocardiographic 
interpretation as it has the potential to extract information not readily apparent to observers. 
For instance, assessing regional wall motion abnormalities (RWMAs), based on a visual 
interpretation of endocardial excursion and myocardial thickening, is subjective and 
experience-dependent. The development of an objective classification model is expected to 
improve the detection of RWMAs in clinical practice. In a recent study, automated diagnosis 
of RWMA by a DL-based algorithm showed diagnostic accuracy comparable to the expert 
consensus assessment.37) Echocardiographic RWMA assessment with AI might not be 
necessary for experts. However, the availability of an objective and quantitative assessment 
of RWMAs, with no intra-observer errors, has tremendous appeal considering its ability to 
increase workflow in daily clinical practice. If these models can be improved using a larger 
cohort, the clinical applications would not be limited to rest echocardiography, but also could 
be expanded to stress echocardiography.
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Myocardial textural characterization is another target for AI applications. Although the 
echocardiographic myocardial texture is dependent upon the ultrasound instrument and 
transducer, it also is influenced by alterations in tissue pathology.38) Therefore, abnormal 
myocardial texture on echocardiography often provides important clues regarding myocardial 
disease.39) However, such myocardial tissue characterizations rely heavily on experience and 
remain subjective. The application of radiomics and AI-based algorithms holds promise in 
echocardiographic interpretation of myocardial textural changes, which are often subtle, 
non-specific, and challenging to quantify.40)41) Radiomics is a process that converts digital 
medical images into mineable high-dimensional data, motivated by the concept that 
biomedical images contain information reflecting the underlying pathophysiology, and 
that relationships can be revealed via quantitative image analyses (Figure 3).42) Although 
radiomics was initiated in oncology using CT, MR, and positron emission tomography 
images,43-45) it is potentially applicable to echocardiography for evaluation of cardiovascular 
disease.40)41)
Although most of the studies have employed supervised ML models to mimic interpretation 
by human expertise, unsupervised clustering algorithms also provide important insights into 
disease by segregating patient groups with similar traits and assigning them into clusters. 
This enables the exploration of possible heterogeneity within a disease category that has 
historically been considered homogeneous.11) For example, in patients with aortic stenosis, 
an unsupervised clustering algorithm applied to echocardiographic features with and without 
clinical features might allow the phenotyping of aortic stenosis and prediction of differential 
outcomes.46)47) Uncovering heterogeneity that would otherwise be undetected using 
traditional classification methods can improve risk stratification and aid in cost-effective 
healthcare utilization toward better diagnosis and treatment.48)
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Image acquisition ROI segmentation
Figure 3. Application of radiomics and AI-based algorithms for myocardial textural change. A ROI is extracted 
from the image for radiomics feature analysis, including intensity and texture features. AI models integrate 
radiomics features in development of the diagnostic model. 
AI: artificial intelligence, ROI: region of interest, GLCM: gray-level co-occurrence matrix, GLRLM: gray-level run 
length matrix, GLSZM: gray-level size zone matrix.
THE CHALLENGES
The most significant barrier to progress in AI applications for echocardiography is the lack 
of large, publicly available, and well-annotated echocardiographic datasets for training.6)23)49) 
Although small datasets can be sufficient for training AI algorithms in research settings, 
large datasets are essential for training, validating, and testing commercial AI applications.50) 
While healthcare organizations store vast amounts of echocardiographic data that could be 
exploited to train AI algorithms, the data usually are stored at an on-premise server, which 
is safe but limits the potential of sharing data with other institutions. Cloud-based storage, 
which is becoming more secure, is expected to improve data sharing as well as data backup.50) 
Even when a large echocardiographic dataset is available for training, it might be unusable 
because most datasets are not curated, organized, anonymized, or appropriately annotated 
and are rarely linked to a ground truth diagnosis. Furthermore, definition of the ground truth 
depends on the desired task or purpose of a given AI algorithm. If the echocardiographic 
finding is the reference standard, annotation performed by experts can be considered as 
ground truth. On the other hand, the ground truth might require confirmatory clinical 
labeling beyond echocardiographic reports, such as a pathologic report, clinical outcome, 
or both.50) Therefore, the task of data preparation for AI algorithm training is inevitably 
time- and labor-intensive. Additionally, to translate AI into broader clinical practice, these 
databases must include sufficient “real-world” heterogeneity, reflecting the spectrum of 
practice and imaging protocols in the field.49) Since the data quality and scope determine the 
applicability and accuracy of AI algorithms regardless of their approach, we hope that recent 
initiatives to develop large echocardiographic databases will facilitate the development of AI 
applications for echocardiography.6)23) Finally, for AI solutions to be properly utilized in daily 
clinical practice and improve the quality of care, not only is development of AI applications 
needed, but the relevant information technology, legal, and institutional environment also 
should be prepared.
FUTURE EXPECTATIONS
The ultimate goal of AI applications in echocardiography is automation of the entire 
process of echocardiographic image analysis. In a recent paper, Zhang et al.19) proposed a 
solution that automatically recognizes echocardiographic views, segments and labels the 
cardiac chambers (including the cavity and myocardium of the LV), calculates classical 
echocardiographic functional parameters and global longitudinal strain, and classifies 
certain cardiac pathologies. Although further studies are required to understand the true 
performance of the proposed automatic analysis pipeline, this study provides a preview 
of the future echocardiographic laboratory. Once the automatic analysis of images has 
become reliable, workflow in clinical echocardiographic laboratories will change radically.25) 
Whereas the expert currently spends much of their time extracting parameters from 
images and mentally integrating them to reach a diagnosis (while applying consensus 
recommendations), the future echocardiographic laboratory automatically will extract all 
relevant numbers and feed them directly into diagnostic algorithms to support decision-
making. The human operator will be the master controlling the overall diagnostic process, 
while computers perform measurements and integrate and compare data on request.
Furthermore, in this system, diagnostic criteria and decision trees will be continuously 
refined and improved by integrating ever-expanding databases so that a given patient’s 
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echocardiographic profile can be matched against millions of validated cases to provide 
not only a diagnosis, but also an estimate of the risk and long-term outcomes related to 
different therapeutic options. Although unsupervised and reinforcement learning are not 
actively used in the field of medical imaging,6)11) they hold promise for development of 
automated risk prediction algorithms that can be used to guide clinical care. Unsupervised 
learning techniques could be used for more precise phenotyping of complex diseases, and 
reinforcement learning algorithms can intelligently augment healthcare providers.51)
CONCLUSION
With the continual evolution of technology, healthcare providers should become well versed 
and able to harness the new knowledge provided by AI. Despite some opinions voiced in 
the public space, AI is unlikely to replace human expertise. Rather, the echocardiographic 
specialist will obtain significant support from computing technology, which will greatly 
reduce the time spent on extracting and integrating data, and in turn, render the healthcare 
system more sustainable.
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